Klaria Pharma Holding AB (publ.) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 6.53 million. Revenue was SEK 6.59 million compared to SEK 0.371 million a year ago.

Net loss was SEK 5.4 million compared to SEK 20.26 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.37 a year ago.